Replies to post #39543 on Biotech Values

[DewDiligence]

>Re: GSK anti CD20 deal. It does not surprise me that Genmab got lots of $$$ for their AB. It does suprise me that it is the biggest biotech deal of all time.<

It’s not the biggest deal ever on an apples to apples basis. In the Erbitux deal for $1.9B, $1.4B was either up-front or unconditional. That’s far cry from the GenMab deal, which is heavily backloaded.